Medical device firm ART Advanced Research Technologies of Montreal has received a patent from the U.S. Patent and Trademark Office for breast physiology imaging, the company said.
Patent number 7,286,869, "Choice of wavelengths for multi-wavelength optical imaging," is for selection of the company's SoftScan optical breast imaging system's optical wavelengths. The use of this method within an optical medical imaging device allows significant improvement in the recovery of precise images of physiological components, according to ART.
SoftScan is designed as a complementary diagnostic tool to mammography for the detection and treatment monitoring of breast cancer.
By AuntMinnie.com staff writers
November 2, 2007
Related Reading
Road to RSNA, ART Advanced Research Technologies, October 26, 2007
ART wins purchase promise for SoftScan, October 25, 2007
ART taps DiCamillo for global sales post, September 7, 2007
ART signs Canadian research deal, September 6, 2007
ART posts 2007 Q2 loss, August 16, 2007
Copyright © 2007 AuntMinnie.com
